Medicis Pharmaceutical Beats Earnings Estimates; Offers Poor Guidance

Medicis Pharmaceutical

released its Q4 earnings results on Monday after the closing bell. The Scottsdale, Arizona based company reported EPS of $0.87 versus analysts' consensus EPS estimates of $0.55. Revenues for the quarter came in at $180.70 million compared to Street consensus of $179.06 million. Looking ahead, MRX sees Q1 EPS between $0.37 and $0.43 versus Street estimates of $0.58. Revenues are expected in a range between $177 and $188 million versus current consensus of $200.2 million for the first quarter. In after hours trading, MRX shares have lost 0.10% to $33.81.